|
Match
|
Document |
Document Title |
|
|
7625905 |
Octahydro-pyrrolo[3,4-c]pyrrole CCR5 receptor antagonists
Chemokine receptor antagonists, in particular, 3,7-diazabicyclo[3.3.0]octane compounds according to formula (I) wherein R 1 -R 3 and Ar are as defined herein are antagonists of chemokine CCR5...
|
|
|
7618967 |
Indane compounds
The invention provides novel indane compounds which are useful in the treatment of affective disorders, pain disorders, attention deficit hyperactivity disorder (ADHD), cognitive disorders,...
|
|
|
7482335 |
Cyclic derivatives as modulators of chemokine receptor activity
The present application describes modulators of MCP-1 of formula (I):
or pharmaceutically acceptable salt forms thereof, useful for the treatment of rheumatoid arthritis, multiple sclerosis,...
|
|
|
7378409 |
Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity
The present application describes modulators of MCP-1 of formula (I):
or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma, multiple sclerosis,...
|
|
|
7365061 |
2-Amino-3-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors
Novel compounds are provided which are glycogen phosphorylase inhibitors which are useful in treating, preventing or slowing the progression of diseases requiring glycogen phosphorylase inhibitor...
|
|
|
7238683 |
Fused phenylalanine derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
The present invention is directed to fused phenylalanine derivatives which are inhibitors of the dipeptidyl peptidase-IV enzyme (“DP-RV inhibitors”) and which are useful in the treatment or...
|
|
|
7232812 |
Substituted azetidine compounds, their preparation and use as medicaments
The present invention relates to substituted Azetidine compounds of general formula (I), methods for their preparation, medicaments comprising these compounds as well as their use for the...
|
|
|
7183270 |
Cyclic derivatives as modulators of chemokine receptor activity
The present application describes modulators of MCP-1 of formula (I):
or pharmaceutically acceptable salt forms thereof, useful for the prevention of rheumatoid arthritis, multiple sclerosis,...
|
|
|
7125863 |
Inhibitors of dipeptidyl peptidase IV
Compounds according to formula (1), wherein R 1 is H or CN, X 1 is S, O, SO 2 or CH 2 , X 2 is CO, CH 2 or a covalent bond, Het is a nitrogen-containing heterocycle and n is 1–5 are new. The...
|
|
|
7067509 |
Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto
Melanin-concentrating hormone (MCH) receptor antagonists are disclosed having utility for the treatment of MCH receptor-based disorders such as obesity. The compounds of this invention have the...
|
|
|
6872717 |
Pharmacological uses of azetidine derivatives
A method of treating or preventing obesity, this method comprising administering to a patient in need of such treatment an effective amount of a compound of formula
in which R, R 3 and R 4 ...
|
|
|
6864249 |
Piperidine and azetidine thrombin inhibitors
The present invention relates to a compound having formula I:
and pharmaceutically acceptable salts thereof. The compounds of formula I and pharmaceutical compositions containing them are of...
|
|
|
6740647 |
Thrombin inhibitors
Novel five-membered heterocyclic amidines, their preparation and use as competitive inhibitors of trypsin-like serine proteases, especially thrombin and kininogenases such as kallikrein....
|
|
|
6645957 |
Cyclic amide compound
The invention relates to compounds represented by the following general formula (1): wherein A is an aromatic compound which may be substituted, or the like, B is a nitrogen atom or CH, X is a...
|
|
|
6599894 |
Amidinobenzylamine derivatives and their use as thrombin inhibitors
There is provided compounds of formula I wherein R 1 , R 2 , Y, R 3 and R 4 have meanings given in the description which are useful as, or as prodrugs of, competitive inhibitors of...
|
|
|
6544976 |
Neurotrophic 2-azetidinecarboxylic acid derivatives, and related compositions and methods
This invention provides compounds having the following general structure: This invention also provides pharmaceutical compositions comprising same and methods of using these compositions to...
|
|
|
6518285 |
Piperidinyloxy and pyrrolidinyloxy oxazolidinone antibacterials
Piperidinyloxy, pyrrolidinyloxyl and azetidinyloxy compounds of the formula: wherein R 1 is a piperidinyl, pyrrolidinyl or azetidinyl moiety as described herein and in which the substituents...
|
|
|
6479479 |
Azetidine derivatives, their preparation and pharmaceutical compositions containing them
Compounds of formula: in which R represents a CR 1 R 2 , C═C(R 5 )SO 2 R 6 or C═C(R 7 )SO 2 alk radical, their preparation and the pharmaceutical compositions containing them.
|
|
|
6448242 |
Cyclic amide compounds
The invention relates to compounds represented by the following general formula (1): wherein A is an aromatic compound which may be substituted, or the like, B is a nitrogen atom or CH, X is a...
|
|
|
6337394 |
Compounds
There is provided compounds of formula I, wherein R 1 , R 2 , R 3 , R x , Y, n and B have meanings given in the description which are useful as competitive inhibitors of trypsin-like proteases,...
|
|
|
6306880 |
Triazole antifungal agent
A triazole compound having the formula: ##STR1## wherein Ar 1 represents a phenyl group which may be substituted; Ar 2 represents a phenyl group which may be substituted; R 0 represents a...
|
|
|
6262045 |
4-Oxo-3,5-dihydro-4H-pyridazino[4,5-b]-indole-1-acetamide derivatives, their preparation and their application in therapy
Compounds of general formula (I) ##STR1## in which X represents a hydrogen or halogen atom or a methyl, methoxy or phenylmethoxy group, Y represents a hydrogen atom, 1 or 2 halogen atoms or a...
|
|
|
6242438 |
3-Azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists
The present invention provides compounds of formula (I) and the pharmaceutically acceptable salts thereof. Such compounds and salts are tachykinin antagonists. ##STR1##
|
|
|
6228853 |
Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
According to the invention are provided compounds of formula (I) (relative stereochemistry indicated) wherein R 1 , R 2 and R 3 are as defined in the specification. Compounds of formula (I) are...
|
|
|
6214841 |
Antithrombotic compound
This application relates to a novel compound of formula (I) (or a pharmaceutically acceptable salt thereof) as defined herein, processes and Intermediates for its preparation, pharmaceutical...
|
|
|
6093731 |
Isoquinolines
Isoquinolinylguanidine compounds of formula (I): ##STR1## wherein the substituents are as defined herein, and salts thereof, are disclosed as urokinase inhibitors.
|
|
|
6077840 |
Tetrahydrobenzindolone derivatives
Compounds represented by the following formula (I) or pharmaceutically acceptable salts thereof and a process for producing the same are disclosed. The compounds have progesterone receptor binding...
|
|
|
6075021 |
1H-pyrido[3,4-b]indole-4-carboxamide derivatives, preparation and application thereof in therapeutics
Compounds of general formula (I) ##STR1## in which the variables are as defined in the specification, their preparation and their application in therapeutics.
|
|
|
6048869 |
Tricyclic compounds
The novel compounds of the present invention are those of structural formula I: ##STR1## or a pharmaceutically acceptable salt, ester, or stereoisomer thereof, which are inhibitors of...
|
|
|
6034067 |
Serine protease inhibitors
The invention relates to a compound having formula (I), wherein A, B, X, N, Z and Q are defined as described in the description. The compounds of the invention have anticoagulant activity and can...
|
|
|
6030984 |
Pyridone compounds useful in treating Alzheimer's disease
The invention is concerned with the use of bi- and tricyclic pyridone compounds of the formula where A, R 1 , R 3 , R 4 , and R 7 are described herein and of their pharmaceutically acceptable...
|
|
|
5952354 |
Tris carbamic acid esters: inhibitors of cholesterol absorption
Inhibition of the enzymes cholesterol ester hydrolase (CEH) and/or acyl coenzyme A: cholesterol acyltransferase (ACAT) results in the inhibition of the esterification of cholesterol and are...
|
|
|
5942523 |
Compounds which are selective antagonists of the human NK.sub.3 receptor and their use as medicinal products and diagnostic tools
A compound of formula: in which: Ar represents a pyrid-2-yl or a phenyl which is unsubstituted or substituted by a halogen, a methyl or a (C 1 -C 4 )alkoxy; R 1 represents a methyl group; ...
|
|
|
5932567 |
Thrombin inhibitors
Thrombin inhibitors of the formula ##STR1## where R 1 , A, B and D have the meaning indicated in the description, and intermediates for the preparation thereof are described. The compounds I are...
|
|
|
5922755 |
Immunomodulator, cell adhesion inhibtor, and agent for treating, and preventing autoimmune diseases
A 4H-1-benzopyran-4-one derivative of the general formura 1!, ##STR1## or a salt thereof exerts excellent effects on immunomodulation and cell adhesion inhibition, and is further expected to have...
|
|
|
5869476 |
Pyrimidinone derivatives
The invention relates to pyrimidinone derivatives and the pharmaceutically acceptable salts thereof having remarkable antagonistic action against angiotensin II receptor, and thus useful in...
|
|
|
5859002 |
HIV protease inhibitors
HIV protease inhibitors, obtainable by chemical synthesis, inhibit or block the biological activity of the HIV protease enzyme, causing the replication of the HIV virus to terminate. These...
|
|
|
5830854 |
Method of treating cystic fibrosis using a tachykinin receptor antagonist
Tachykinin receptor antagonists are useful for the treatment of cystic fibrosis.
|
|
|
5827847 |
Treatment of cognitive disorders with piperazine derivatives
Piperazine derivatives of formula (I) are useful in the treatment of cognitive disorders. In formula (I), X is a group of (IIa): --(CH 2 ) n CR 2 R 3 CONR 4 R 5 or (IIIb): --A--NR 6 COR 7 ...
|
|
|
5741799 |
Heterocyclic thrombin inhibitors
Heterocyclic thrombin inhibitors are provided which have the structure ##STR1## wherein n, R, R 1 , R 2 , R 3 , G, G x , R 6 ', Ra, Xa, R 6 , Rb, R 3 , p, Q, A and R 4 are as defined herein.
|
|
|
5710149 |
Piperazine derivatives as 5-ht antagonists
This invention concerns compounds of formula (I) ##STR1## where A is a C 1 or C 2 alkylene chain optionally substituted by lower alkyl; Z is a bicyclic oxygen-containing aryl radical (e.g....
|
|
|
5705497 |
3-alkoxycarbonyl-thiadiazinones
3-Alkoxycarbonyl thiadiazinones of the formula I ##STR1## and physiologically unobjectionable salts thereof, in which R 1 , R 2 , R 3 , R 4 , R 5 , Q and n have the meanings described herein,...
|
|
|
5693633 |
Angiotensin II antagonists
This invention provides novel heterocyclic derivatives, their pharmaceutical formulations, and their use for antagonizing angiotensin II receptors in mammals.
|
|
|
5691329 |
Compounds containing basic and acidic termini useful as fibrinogen receptor antagonists
This invention relates to novel compounds containing basic and acidic termini, pharmaceutical compositions containing such compounds, processes for preparing such compounds, and to methods of using...
|
|
|
5627177 |
Piperazine derivatives
Piperazine derivatives of formula (I) and their pharmaceutically acceptable salts are 5-HT 1A binding agents and may be used, for example, as anxiolytics. In the formula, A is an optionally...
|
|
|
5618834 |
Indole derivatives in the treatment of emesis
Compounds of formula I, ##STR1## wherein R 1 represents hydrogen; R 2 represents hydrogen, halogen, cyano, OR 4 , --(CH 2 ) m CONR 5 R 6 , --(CH 2 ) m SO 2 NR 5 R 6 , --(CH 2 ) m NR 7 COR...
|
|
|
5614535 |
Adhesion receptor antagonists
Compounds of the formula I ##STR1## in which R 1 and X have the meanings herein defined, their physiologically unobjectionable salts and/or solvates inhibit the binding of fibrinogen to the...
|
|
|
5585374 |
Amide derivatives
Amide derivatives of formula (I) and their pharmaceutically acceptable salts (where a and b each represent 0, 1, 2 or 3 such that a+b=0, 1, 2 or 3, the dotted line represents an optional double...
|
|
|
5527794 |
Pyrido[3,4-b]indole derivatives as serotonergic agents
The compound of the formula: ##STR1## where R 1 and R 5 are independently hydrogen, fluorine, chlorine, bromine, iodine, trifluoromethyl, cyano, nitro, CO 2 H, C 1 -C 6 alkyl, C 2 -C 10 ...
|
|
|
5491142 |
2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful as inhibitors of enkephalinase
The present invention relates to novel 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives which are useful as inhibitors of Enkephalise.
|